Poster — Thur Eve — 73: Prediction of risks of cardiac mortality and secondary cancers after radiotherapy for Hodgkin's lymphoma, non‐Hodgkin's lymphoma, and breast cancer

Abstract

IMPT may significantly reduce the risks of radiation-induced cardiac mortality and secondary cancer in the lungs and breasts of young patients receiving radiotherapy for HL, NHL, or breast cancer.